Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€70.80

€70.80

-4.440%
-3.29
-4.440%
€89.73
 
14:07 / Tradegate WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Dexcom Inc. Stock

Dexcom Inc. took a tumble today and lost -€3.290 (-4.440%).
The stock is an absolute favorite of our community with 30 Buy predictions and no Sell predictions.
With a target price of 89 € there is a positive potential of 25.71% for Dexcom Inc. compared to the current price of 70.8 €.
Our community identified positive and negative aspects for Dexcom Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Dexcom Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.

Pros and Cons of Dexcom Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Dexcom Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Dexcom Inc. -4.440% 7.439% -1.932% -30.025% -1.868% 4.176% -17.906%
Henry Schein Inc. -0.060% -0.161% 0.649% 3.575% -7.074% -15.335% 19.969%
Teleflex Inc. -0.510% -0.990% -5.660% -47.644% -40.476% -57.265% -68.153%
Baxter International 0.620% -0.753% -4.301% -17.707% -7.654% -58.068% -66.467%

Comments

Prediction Buy
Perf. (%) -0.92%
Target price 88.454
Change
Ends at 16.06.26

DexCom, Inc. (NASDAQ: DXCM) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $102.00 price target on the stock.
Ratings data for DXCM provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -6.24%
Target price 91.562
Change
Ends at 30.05.26

DexCom, Inc. (NASDAQ: DXCM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $104.00 price target on the stock.
Ratings data for DXCM provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -5.84%
Target price 89.954
Change
Ends at 22.05.26

DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Citigroup Inc. from $82.00 to $102.00. They now have a "buy" rating on the stock.
Ratings data for DXCM provided by MarketBeat
Show more

News

Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025: https://mms.businesswire.com/media/20250618841089/en/2501247/5/Lance_Bass_Headshot_2025_%281%29.jpg
Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025


DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th Scientific Sessions of the

Prediction: These 2 Stocks Will Beat the Market in the Next Decade: https://g.foolcdn.com/editorial/images/819382/patient-self-administering-a-shot.jpg
Prediction: These 2 Stocks Will Beat the Market in the Next Decade

Investors typically want to beat the market over the long run. Though it's not an easy task, it certainly is possible with the right companies. Let's consider two corporations that could help you do

Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO: https://mms.businesswire.com/media/20250513806482/en/2467709/5/8180_SD_HEADSHOTS_FORSOCIALMEDIA.jpg
Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president, in addition to his current role as chief